These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 31201367

  • 1. miR-26a promotes hepatocellular carcinoma invasion and metastasis by inhibiting PTEN and inhibits cell growth by repressing EZH2.
    Zhao WT, Lin XL, Liu Y, Han LX, Li J, Lin TY, Shi JW, Wang SC, Lian M, Chen HW, Sun Y, Xu K, Jia JS, Luo RC, Xiao D.
    Lab Invest; 2019 Oct; 99(10):1484-1500. PubMed ID: 31201367
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2.
    Ma DN, Chai ZT, Zhu XD, Zhang N, Zhan DH, Ye BG, Wang CH, Qin CD, Zhao YM, Zhu WP, Cao MQ, Gao DM, Sun HC, Tang ZY.
    J Hematol Oncol; 2016 Jan 06; 9():1. PubMed ID: 26733151
    [Abstract] [Full Text] [Related]

  • 3. miR-26a promoted by interferon-alpha inhibits hepatocellular carcinoma proliferation and migration by blocking EZH2.
    Wang G, Sun Y, He Y, Ji C, Hu B, Sun Y.
    Genet Test Mol Biomarkers; 2015 Jan 06; 19(1):30-6. PubMed ID: 25494962
    [Abstract] [Full Text] [Related]

  • 4. Long noncoding RNA Linc01296 promotes hepatocellular carcinoma development through regulation of the miR-26a/PTEN axis.
    Zhang L, Hu J, Hao M, Bu L.
    Biol Chem; 2020 Feb 25; 401(3):407-416. PubMed ID: 31318685
    [Abstract] [Full Text] [Related]

  • 5. A double-negative feedback loop between EZH2 and miR-26a regulates tumor cell growth in hepatocellular carcinoma.
    Zhuang C, Wang P, Huang D, Xu L, Wang X, Wang L, Hu L.
    Int J Oncol; 2016 Mar 25; 48(3):1195-204. PubMed ID: 26781064
    [Abstract] [Full Text] [Related]

  • 6. MiR-137 suppresses migration and invasion by targeting EZH2-STAT3 signaling in human hepatocellular carcinoma.
    Huang B, Huang M, Li Q.
    Pathol Res Pract; 2018 Dec 25; 214(12):1980-1986. PubMed ID: 30274685
    [Abstract] [Full Text] [Related]

  • 7. The tumor suppressive miR-26a regulation of FBXO11 inhibits proliferation, migration and invasion of hepatocellular carcinoma cells.
    Ma Y, Deng F, Li P, Chen G, Tao Y, Wang H.
    Biomed Pharmacother; 2018 May 25; 101():648-655. PubMed ID: 29518611
    [Abstract] [Full Text] [Related]

  • 8. Long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 cooperates with enhancer of zeste homolog 2 to promote hepatocellular carcinoma development by modulating the microRNA-22/Snail family transcriptional repressor 1 axis.
    Chen S, Wang G, Tao K, Cai K, Wu K, Ye L, Bai J, Yin Y, Wang J, Shuai X, Gao J, Pu J, Li H.
    Cancer Sci; 2020 May 25; 111(5):1582-1595. PubMed ID: 32129914
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. MiR-371 promotes proliferation and metastasis in hepatocellular carcinoma by targeting PTEN.
    Wang H, Zhao Y, Chen T, Liu G, He N, Hu H.
    BMB Rep; 2019 May 25; 52(5):312-317. PubMed ID: 30940319
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Homeobox B9 promotes the invasion and metastasis of hepatocellular carcinoma cells via the EZH2-MIR203A-SNAI2 axis.
    Zhang D, Qiu Y, Zhang W, Du D, Liu Y, Liu L, Li J, Chen Z, Yu X, Ye M, Wang W, Li Z, Shao J.
    J Transl Med; 2024 Oct 10; 22(1):918. PubMed ID: 39390614
    [Abstract] [Full Text] [Related]

  • 13. HANR promotes hepatocellular carcinoma progression via miR-214/EZH2/TGF-β axis.
    Shi Y, Yang X, Xue X, Sun D, Cai P, Song Q, Zhang B, Qin L.
    Biochem Biophys Res Commun; 2018 Nov 17; 506(1):189-193. PubMed ID: 30342849
    [Abstract] [Full Text] [Related]

  • 14. miR-367 promotes proliferation and invasion of hepatocellular carcinoma cells by negatively regulating PTEN.
    Meng X, Lu P, Fan Q.
    Biochem Biophys Res Commun; 2016 Jan 29; 470(1):187-191. PubMed ID: 26772880
    [Abstract] [Full Text] [Related]

  • 15. The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2.
    Zheng F, Liao YJ, Cai MY, Liu YH, Liu TH, Chen SP, Bian XW, Guan XY, Lin MC, Zeng YX, Kung HF, Xie D.
    Gut; 2012 Feb 29; 61(2):278-89. PubMed ID: 21672940
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-26a inhibits angiogenesis by down-regulating VEGFA through the PIK3C2α/Akt/HIF-1α pathway in hepatocellular carcinoma.
    Chai ZT, Kong J, Zhu XD, Zhang YY, Lu L, Zhou JM, Wang LR, Zhang KZ, Zhang QB, Ao JY, Wang M, Wu WZ, Wang L, Tang ZY, Sun HC.
    PLoS One; 2013 Feb 29; 8(10):e77957. PubMed ID: 24194905
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. PTEN inhibits the migration and invasion of HepG2 cells by coordinately decreasing MMP expression via the PI3K/Akt pathway.
    Tian T, Nan KJ, Guo H, Wang WJ, Ruan ZP, Wang SH, Liang X, Lu CX.
    Oncol Rep; 2010 Jun 29; 23(6):1593-600. PubMed ID: 20428814
    [Abstract] [Full Text] [Related]

  • 20. miR-206 inhibits cell proliferation, invasion, and migration by down-regulating PTP1B in hepatocellular carcinoma.
    Yang Q, Zhang L, Zhong Y, Lai L, Li X.
    Biosci Rep; 2019 May 31; 39(5):. PubMed ID: 31048362
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.